Docket Number:
FDA-2017-D-0120
Issued by:
Guidance Issuing Office
Center for Tobacco Products

This guidance document is intended to assist retailers who sell newly deemed products by explaining whether engaging in certain activities subjects such establishments to additional requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and identifying the limited circumstances under which FDA does not intend to enforce compliance. This guidance document discusses, among other things:

  • Definitions
  • FDA’s interpretation of and compliance policy for the label requirement in section 903(a)(2)(C) of the FD&C Act
  • Which vape shop activities subject vape shops to certain requirements of the FD&C Act
  • Limited circumstances under which FDA does not intend to enforce compliance

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2017-D-0120.

Questions?